Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment.

MLA

Eckert, C., et al. “Monitoring Minimal Residual Disease in Children with High-Risk Relapses of Acute Lymphoblastic Leukemia: Prognostic Relevance of Early and Late Assessment.” Leukemia, vol. 29, no. 8, Aug. 2015, pp. 1648–55. EBSCOhost, https://doi.org/10.1038/leu.2015.59.

APA

Eckert, C., Hagedorn, N., Sramkova, L., Mann, G., Panzer-Grümayer, R., Peters, C., Bourquin, J.-P., Klingebiel, T., Borkhardt, A., Cario, G., Alten, J., Escherich, G., Astrahantseff, K., Seeger, K., Henze, G., & von Stackelberg, A. (2015). Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment. Leukemia, 29(8), 1648–1655. https://doi.org/10.1038/leu.2015.59

Chicago

Eckert, C, N Hagedorn, L Sramkova, G Mann, R Panzer-Grümayer, C Peters, J-P Bourquin, et al. 2015. “Monitoring Minimal Residual Disease in Children with High-Risk Relapses of Acute Lymphoblastic Leukemia: Prognostic Relevance of Early and Late Assessment.” Leukemia 29 (8): 1648–55. doi:10.1038/leu.2015.59.